NSCLC Connect
  • Saved

Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers - PubMed

Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34310819/

ALK, ROS1, and RET kinase fusions are important predictive biomarkers of tyrosine kinase inhibitors (TKIs) in non-small-cell lung cancer (NSCLC). Analysis of cell-free DNA (cfDNA) provides a noninvasive method to...

  • Saved

Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer - PubMed

Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34409252/

1 Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. 2 Department of Radiology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China....

  • Saved

Knowledge about risks, benefits, and curative potential of immunotherapy among patients with advanced cancer - PubMed

Knowledge about risks, benefits, and curative potential of immunotherapy among patients with advanced cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34409698/

doi: 10.1002/onco.13945. Online ahead of print. 1 Division of Palliative Care and Geriatrics, Massachusetts General Hospital, Boston, MA, 02114. 2 Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA,...

  • Saved

Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy - PubMed

Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34409906/

doi: 10.1080/07357907.2021.1970761. Online ahead of print. 1 Department of Oncology, Queen Alexandra University Hospital, Portsmouth Hospitals NHS Trust, United Kingdom. 2 Department of Experimental Oncology, Mediterranean Institute of Oncology (IOM),...